Medibelge S.A. Sustainability Profile
Medibelge S.A., a prominent player in the pharmaceutical and biotechnology industry, is headquartered in Belgium (BE) and operates extensively across Europe. Founded in the early 2000s, the company has established itself as a leader in the development and distribution of innovative healthcare solutions, particularly in the fields of generic medicines and specialty pharmaceuticals. Medibelge S.A. is renowned for its commitment to quality and compliance, offering a diverse portfolio of products that cater to various therapeutic areas. The company’s unique approach combines advanced technology with rigorous research, ensuring that its offerings meet the highest industry standards. With a strong market position, Medibelge S.A. has achieved significant milestones, including strategic partnerships and a growing presence in international markets, solidifying its reputation as a trusted name in healthcare.
DitchCarbon Score
How does Medibelge S.A.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medibelge S.A.'s score of 41 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medibelge S.A., headquartered in Belgium, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of emeis Société anonyme, which may influence its climate commitments and reporting practices. While no specific reduction targets or achievements are documented for Medibelge S.A., it is important to note that emissions data and performance metrics may be inherited from its parent company, emeis Société anonyme. This relationship suggests that any climate initiatives or targets may align with those set by emeis Société anonyme, although specific details are not provided. As of now, Medibelge S.A. has not publicly committed to any climate pledges or reduction initiatives, which may reflect a broader industry context where many companies are still developing their sustainability strategies. The lack of reported emissions data and reduction targets highlights an opportunity for Medibelge S.A. to enhance its climate commitments and transparency in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 90,291,000 | 00,000,000 |
| Scope 2 | 61,354,000 | 00,000,000 |
| Scope 3 | 374,010,000 | 000,000,000 |
How Carbon Intensive is Medibelge S.A.'s Industry?
How Carbon Intensive is Medibelge S.A.'s Location?
Medibelge S.A.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medibelge S.A. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
